TY  - GEN
AU  - Yang,S C
AU  - Grimm,E A
AU  - Parkinson,D R
AU  - Carinhas,J
AU  - Fry,K D
AU  - Mendiguren-Rodriguez,A
AU  - Licciardello,J
AU  - Owen-Schaub,L B
AU  - Hong,W K
AU  - Roth,J A
TI  - Clinical and immunomodulatory effects of combination immunotherapy with low-dose interleukin 2 and tumor necrosis factor alpha in patients with advanced non-small cell lung cancer: a phase I trial
SN  - 0008-5472
PY  - 1991///0812
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Antigens, Surface
KW  - analysis
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Carcinoma, Non-Small-Cell Lung
KW  - immunology
KW  - Drug Evaluation
KW  - Humans
KW  - Interleukin-2
KW  - administration & dosage
KW  - Killer Cells, Lymphokine-Activated
KW  - Killer Cells, Natural
KW  - Lung Neoplasms
KW  - Middle Aged
KW  - T-Lymphocytes
KW  - Tumor Necrosis Factor-alpha
N1  - Publication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S
ER  -